TGFB1 and neoplasm: Tumor-associated macrophages that are CD163+ and ARG1+, and myeloid-derived suppressor cells expand in dysplastic and early carcinoma niches and release IL-10, TGF-β, and PGE2, which blunt T-cell activation and antigen presentation (37).